rs201979617
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBS1BS2
The ENST00000507735.6(PALLD):c.342_344dup(p.Pro115dup) variant causes a inframe insertion change. The variant allele was found at a frequency of 0.00196 in 1,478,304 control chromosomes in the GnomAD database, including 31 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 30 hom. )
Consequence
PALLD
ENST00000507735.6 inframe_insertion
ENST00000507735.6 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.07
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM4
?
Nonframeshift variant in NON repetitive region in ENST00000507735.6. Strenght limited to Supporting due to length of the change: 1aa.
BP6
?
Variant 4-168878227-G-GCCA is Benign according to our data. Variant chr4-168878227-G-GCCA is described in ClinVar as [Benign]. Clinvar id is 476388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
?
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00547 (798/145980) while in subpopulation SAS AF= 0.022 (96/4370). AF 95% confidence interval is 0.0184. There are 1 homozygotes in gnomad4. There are 398 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High AC in GnomAd4 at 798 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PALLD | NM_001166108.2 | c.1965-12689_1965-12687dup | intron_variant | ENST00000505667.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PALLD | ENST00000505667.6 | c.1965-12689_1965-12687dup | intron_variant | 1 | NM_001166108.2 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00545 AC: 795AN: 145908Hom.: 1 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
795
AN:
145908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00398 AC: 446AN: 112030Hom.: 8 AF XY: 0.00504 AC XY: 312AN XY: 61874
GnomAD3 exomes
AF:
AC:
446
AN:
112030
Hom.:
AF XY:
AC XY:
312
AN XY:
61874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00158 AC: 2100AN: 1332324Hom.: 30 Cov.: 46 AF XY: 0.00203 AC XY: 1332AN XY: 657616
GnomAD4 exome
AF:
AC:
2100
AN:
1332324
Hom.:
Cov.:
46
AF XY:
AC XY:
1332
AN XY:
657616
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00547 AC: 798AN: 145980Hom.: 1 Cov.: 32 AF XY: 0.00559 AC XY: 398AN XY: 71232
GnomAD4 genome
?
AF:
AC:
798
AN:
145980
Hom.:
Cov.:
32
AF XY:
AC XY:
398
AN XY:
71232
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
24
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PALLD p.Pro115dup variant was not identified in the literature nor was it identified in COSMIC. The variant was identified in dbSNP (ID: rs201979617) and ClinVar (classified as benign by Invitae). The variant was identified in control databases in 597 of 142532 chromosomes (8 homozygous) at a frequency of 0.004189 (Genome Aggregation Database March 6, 2019, v2.1.1). This variant is an in-frame insertion resulting in the duplication of a proline (pro) residue at codon 115; the impact of this alteration on PALLD protein function is not known. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. - |
Pancreatic adenocarcinoma Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 27, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at